Published in Epilepsia on September 01, 2006
Hormonal contraception--what kind, when, and for whom? Dtsch Arztebl Int (2011) 2.47
Clinical pharmacokinetic interactions between antiepileptic drugs and hormonal contraceptives. Expert Rev Clin Pharmacol (2010) 1.02
Controversies in contraception for women with epilepsy. Ann Indian Acad Neurol (2015) 0.77
Skin nerve α-synuclein deposits: a biomarker for idiopathic Parkinson disease. Neurology (2014) 2.31
Severe impairment of complex I-driven adenosine triphosphate synthesis in leber hereditary optic neuropathy cybrids. Arch Neurol (2005) 2.17
Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat Genet (2013) 2.10
Movement disorders in sleep: guidelines for differentiating epileptic from non-epileptic motor phenomena arising from sleep. Sleep Med Rev (2007) 2.00
Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations. Ann Neurol (2014) 1.62
Progressive myoclonic epilepsies: definitive and still undetermined causes. Neurology (2014) 1.52
Physiologic autonomic arousal heralds motor manifestations of seizures in nocturnal frontal lobe epilepsy: implications for pathophysiology. Sleep Med (2012) 1.51
Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. J Biol Chem (2004) 1.50
Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32. Hum Mol Genet (2012) 1.48
Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy. Ann Neurol (2004) 1.40
Idebenone treatment in Leber's hereditary optic neuropathy. Brain (2011) 1.39
Autosomal dominant lateral temporal epilepsy: clinical spectrum, new epitempin mutations, and genetic heterogeneity in seven European families. Epilepsia (2003) 1.27
Levetiracetam therapy in patients with brain tumour and epilepsy. J Neurooncol (2006) 1.26
Sleep disorders in patients with spinal cord injury. Sleep Med Rev (2013) 1.22
Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments. Epilepsia (2011) 1.20
Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies. Brain (2006) 1.18
Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies. J Neuroimmunol (2008) 1.10
Increased frequency of arousal parasomnias in families with nocturnal frontal lobe epilepsy: a common mechanism? Epilepsia (2010) 1.08
Multidetector CT of the paranasal sinus: potential for radiation dose reduction. Radiology (2007) 1.06
The ND1 gene of complex I is a mutational hot spot for Leber's hereditary optic neuropathy. Ann Neurol (2004) 1.05
Autosomal dominant lateral temporal epilepsy: absence of mutations in ADAM22 and Kv1 channel genes encoding LGI1-associated proteins. Epilepsy Res (2008) 1.04
Diffusion-tensor magnetic resonance imaging detects normal-appearing white matter damage unrelated to short-term disease activity in patients at the earliest clinical stage of multiple sclerosis. Arch Neurol (2005) 1.01
Arousal elicits exaggerated inhibition of sympathetic nerve activity in phobic syncope patients. Brain (2007) 1.00
Successful transvenous embolization of brain arteriovenous malformations using Onyx in five consecutive patients. Neurosurgery (2011) 0.99
Excessive daytime sleepiness and subjective sleep quality in patients with nocturnal frontal lobe epilepsy: a case-control study. Epilepsia (2006) 0.98
Solitaire AB stent-assisted coiling of wide-necked intracranial aneurysms: short-term results from a prospective, consecutive, European multicentric study. Neuroradiology (2013) 0.98
Unexpected gamma glutamyltransferase rise increase during levetiracetam monotherapy. Epileptic Disord (2010) 0.97
Mitochondrial DNA nucleotide changes C14482G and C14482A in the ND6 gene are pathogenic for Leber's hereditary optic neuropathy. Ann Neurol (2002) 0.95
Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs. Epilepsia (2006) 0.95
Genome-wide linkage meta-analysis identifies susceptibility loci at 2q34 and 13q31.3 for genetic generalized epilepsies. Epilepsia (2012) 0.94
Solitaire AB stent-assisted coiling of wide-necked intracranial aneurysms: mid-term results from the SOLARE Study. Neurosurgery (2014) 0.94
miRNAs expression analysis in paired fresh/frozen and dissected formalin fixed and paraffin embedded glioblastoma using real-time pCR. PLoS One (2012) 0.93
Lateralizing value of the auditory aura in partial seizures. Epilepsia (2006) 0.93
Small nerve fiber involvement in patients referred for fibromyalgia. Muscle Nerve (2014) 0.93
Small fiber neuropathy in female patients with fabry disease. Muscle Nerve (2010) 0.92
Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference. PLoS One (2013) 0.92
Defective mitochondrial adenosine triphosphate production in skeletal muscle from patients with dominant optic atrophy due to OPA1 mutations. Arch Neurol (2010) 0.91
Knowledge and attitudes toward epilepsy among primary and secondary schoolteachers in Italy. Epilepsy Behav (2011) 0.90
Seizure outcome of epilepsy surgery in focal epilepsies associated with temporomesial glioneuronal tumors: lesionectomy compared with tailored resection. J Neurosurg (2009) 0.90
Patterns of prescription of antiepileptic drugs in patients with refractory epilepsy at tertiary referral centres in Italy. Epilepsy Res (2010) 0.90
Biochemical-clinical correlation in patients with different loads of the mitochondrial DNA T8993G mutation. Arch Neurol (2002) 0.89
Sudden unexpected death in epilepsy (SUDEP): a pilot study on truth telling among Italian epileptologists. Neurol Sci (2010) 0.88
A de novo LGI1 mutation in sporadic partial epilepsy with auditory features. Ann Neurol (2004) 0.88
Immunoproteasome in cancer and neuropathologies: a new therapeutic target? Curr Pharm Des (2013) 0.88
Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. Ther Drug Monit (2004) 0.87
Prognostic factors in patients with mesial temporal lobe epilepsy. Epilepsia (2009) 0.87
Nocturnal frontal lobe epilepsy. Curr Neurol Neurosci Rep (2014) 0.87
Does the prion protein gene 129 codon polymorphism influence sleep? Evidence from a fatal familial insomnia kindred. Clin Neurophysiol (2002) 0.87
Atypical late-onset hereditary spastic paraplegia with thin corpus callosum due to novel compound heterozygous mutations in the SPG11 gene. J Neurol (2014) 0.87
Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.86
Habituation of sympathetic sudomotor and vasomotor skin responses: neural and non-neural components in healthy subjects. Clin Neurophysiol (2005) 0.86
Praxis-induced seizures misdiagnosed as cataplexy: a case report. Mov Disord (2008) 0.86
Brain diffusion-weighted imaging in Friedreich's ataxia. Mov Disord (2011) 0.86
The long-term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy: the PuLsE (Open Prospective Randomized Long-term Effectiveness) trial. Epilepsia (2014) 0.86
Complex segmental duplications mediate a recurrent dup(X)(p11.22-p11.23) associated with mental retardation, speech delay, and EEG anomalies in males and females. Am J Hum Genet (2009) 0.85
Epilepsy in primary cerebral tumors: the characteristics of epilepsy at the onset (results from the PERNO study--Project of Emilia Romagna Region on Neuro-Oncology). Epilepsia (2013) 0.85
Diagnostic accuracy of a structured interview for nocturnal frontal lobe epilepsy (SINFLE): a proposal for developing diagnostic criteria. Sleep Med (2011) 0.85
Low penetrance of autosomal dominant lateral temporal epilepsy in Italian families without LGI1 mutations. Epilepsia (2013) 0.85
Autosomal dominant early-onset cortical myoclonus, photic-induced myoclonus, and epilepsy in a large pedigree. Epilepsia (2006) 0.85
Interobserver reliability of ICSD-R minimal diagnostic criteria for the parasomnias. J Neurol (2005) 0.84
Simple and validated HPLC-UV analysis of levetiracetam in deproteinized plasma of patients with epilepsy. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.84
Anhidrosis in multiple system atrophy: a preganglionic sudomotor dysfunction? Mov Disord (2008) 0.84